Journal of Cardiovascular Pharmacology and Therapeutics
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 2.9 | Q2 | 60.3% | 0.829 | Q2 | 78.4% |
| 2024 | 2.8 | Q2 | 63.9% | 0.858 | Q2 | 80.0% |
| 2023 | 2.5 | Q3 | 50.3% | 0.696 | Q2 | 75.5% |
| 2022 | 2.6 | Q3 | 44.3% | 0.650 | Q2 | 74.5% |
| 2021 | 2.8 | Q3 | 47.0% | 0.685 | Q2 | 76.8% |
| 2020 | — | — | 0.787 | Q2 | 79.4% | |
| 2019 | — | — | 0.674 | Q2 | 76.0% | |
| 2018 | — | — | 0.877 | Q2 | 80.9% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1940-4034
ISSN
1074-2484
country
coverage
1996-2025
